@ACVCPresident @carlosalviar @franciscojlk @rafavidalperez @STEMIindia @StentSaveLife @EAPCIPresident @EAPCPresident @alfocandiello @manuelchacon202 @gt_acs @ICBAonline @APCyCCV @AjitMullasari @smexcardiologia @SIAC_cardio @congresoC3 @JulioEffio @paomorejon @CNIC_CARDIO @MedscapeES @gonzaeperez The consensus emphasizes that these models, while pragmatic, are a starting point. Success requires continuous improvement, patient education campaigns, and adapting strategies to local realities. You can now read the full access paper in: https://t.co/mH3P6ACSOT #MedTwitter

@ACVCPresident @carlosalviar @franciscojlk @rafavidalperez @STEMIindia @StentSaveLife @EAPCIPresident @EAPCPresident @alfocandiello @manuelchacon202 @gt_acs @ICBAonline @APCyCCV @AjitMullasari @smexcardiologia @SIAC_cardio @congresoC3 @JulioEffio @paomorejon @CNIC_CARDIO @MedscapeES @gonzaeperez 6 Finally, the clinical consensus provides advise on frequently faced, complex scenarios, including 🏳️Delayed access to pPCI 🏳️Delayed pPCI in cardiogenic shock 🏳️Delayed pPCI & high bleeding risk 🏳️No access to fibrin-specific Lytics. 🏳️Delayed access to scheduled pCI, etc

She waited two hours for a word. God told her she already had it. Listen to this lesson about hearing God. It could change your life.

@ACVCPresident @carlosalviar @franciscojlk @rafavidalperez @STEMIindia @StentSaveLife @EAPCIPresident @EAPCPresident @alfocandiello @manuelchacon202 @gt_acs @ICBAonline @APCyCCV @AjitMullasari @smexcardiologia @SIAC_cardio @congresoC3 5 Beyond the proposal of each model, we also delineate a pathway for setting up a STEMI system of care in regions with no prior access, emphasizing the importance and key role of Telemedicine & Patient Awareness.

@ACVCPresident @carlosalviar @franciscojlk @rafavidalperez @STEMIindia @StentSaveLife @EAPCIPresident @EAPCPresident @alfocandiello @manuelchacon202 @gt_acs @ICBAonline @APCyCCV 4 The consensus proposes a flexible, three-model pathway—based on a hub-and-spoke system—that can be adapted to local circumstances. The choice of the model depends on the availability of resources, and should strive for advancing quality and access.

@ACVCPresident @carlosalviar @franciscojlk @rafavidalperez @STEMIindia @StentSaveLife @EAPCIPresident @EAPCPresident @alfocandiello @manuelchacon202 @gt_acs @ICBAonline @APCyCCV 3 The challenges are multifactorial: -Patient delays: lack of awareness, fear of cost, and cultural beliefs. -System delays: poor transportation, lack of trained staff/equipment. -Resource constraints: high cost of facilities and essential medicines.

Get it before the ice melts.

@ACVCPresident @carlosalviar @franciscojlk @rafavidalperez @STEMIindia @StentSaveLife @EAPCIPresident @EAPCPresident 2 Why is this needed? In North America & Europe, over 90% of STEMI patients get reperfusion therapy, but in many LMICs, rates are alarmingly low—sometimes less than 50%. Furthermore, most (>60%) LMICs have no reliable data. This leads to preventable deaths and complications.

Is STEMI reperfusion a satisfied need? 🚩NO! - Most developing countries still face significant barriers for reperfusion So, let me take you through our new "Clinical Consensus Statement for STEMI reperfusion in LMICs, representing ACVC, EAPCI, EAPC, ESCWGT & SSL" A tweetorial

👉In the wake of the Scandinavian Simvastatin Survival Study trial (4S) ☝️Must read! 👉Thirty years after the 4S trial, the verdict is indisputable: LDL-C causes ASCVD, and lowering it early and for life saves lives. 👉Statins are safe, cheap, and the cornerstone of

We’re beyond excited for the new edition of ACVC School! 🌍 Join us and our renowned international faculties for a game-changing experience @emireles_c @AndreaElliottUM @drdargaray @carlosalviar @sionis_a @simulacioVH https://t.co/zslSAhW6L6

FUTURES TRADERS: Get 40% off all evals, no activation fees, end-of-day drawdown in our live-market PRO+ accounts…and still daily PRO payouts!

Desde hace 3 años, con el surgimiento de los antagonistas del receptor GLP-1 como Ozempic®, han circulado opiniones que van de lo absurdo a lo francamente ignorante. Gente opinando sin idea del mecanismo de acción ni del contexto clínico en que se usan. Hilo 🧵...

We are excited for the 3rd annual @UMN_CCCEdSummit on June 4-6, 2025, at UMN's East Bank Campus. We are thrilled to be sponsoring Dr. Guadalupe Lisseth Hernandez Gonzalez to attend the Summit! The CCCES is in collaboration with @SocietyOfCCC and @CardioNerds. #UMN_CCCEdSummit

Think bigger. The #CSWG Global Summit drops June 4 ⚡ — unfiltered debates, lightning talks, real-world shock cases. Free. Virtual. Unmissable. Register now: https://t.co/3l8gFeEAHY #CardioICU #ShockWave #HeartFailure #CSWG2025 #MCS 🫀🧠⚡

Estoy muy feliz de pertenecer a la tercera generación de #Publicamed, agradecido de tantos conocimientos nuevos para mi carrera. Agradecido infinitamente con el Dr. @drdargaray por sus enseñanzas.

Felicitaciones @Cardiologia_Mx por liderar con el ejemplo y confiar en investigadores clinicos talentosos participando en registros internacionales para mejorar el cuidado de los pacientes con choque cardiogenico en 🇲🇽 y el 🌎 @ISHLT @TheJHLT #ISHLTenEspañol @Jorgeheartshock

The San Juan de Dios General Hospital team presented two abstracts at ACC.25 meeting — one on behalf of Fundación Aldo Castañeda’s CHD program, another on Guatemala’s first public Cath Lab. Both published in JACC Journals!

🌟 **Join Us!** The Cardiogenic Shock Working Group 2025 Global Summit is on Wednesday, June 4, 2025, and it’s **FREE!** Don’t miss the chance to connect and learn! Register today! 🎉 https://t.co/Y3VWbzGa3q #CSWG25 #CardiogenicShock

Looking forward to @ISHLT 1st ever #cardiogenicshock & joint #CSWG symposium! Both events promise to highlight the potential of 🌎 collaboration as a multidimensional platform that helps improve care for patients with advanced ❤️‍🩹 disease ❤️ https://t.co/Bf9rs5a5cN @NavinKapur4

@david_enze_wang @LeivaOrly @CardsNYC @SamuelB316 @jason_bartos @PennyRampersad @AlexPapolos @PabloJ @FH_Verbrugge @HannahSchaubro1 @JFleitmanMD @cccm_bkl @AndreaElliottUM @ConnorObrienMD @Sam_Brusca @drdargaray @rafavidalperez @JordiBaneras @krychtiukmd @JCiancarelliDO

👉 Low-density lipoprotein cholesterol levels and risk of incident dementia: a distributed network analysis using common data models ☝️WHAT THIS STUDY ADDS ⇒ LDL-C levels below 70 mg/dL (1.8 mmol/L) are associated with a significant reduction in the risk of all-cause dementia

I can’t believe it! People showed up to the Inaugural ⁦@SocietyOfCCC⁩ Meeting in conjunction with ⁦@HoustonShockHSS⁩ - so thankful for EVERYONE! ⁦@JumeanMarwan⁩ ⁦@BalimSenmanMD⁩ ⁦@nyulangone⁩